Genetic links to ADHD, autism and depression changed with age

	ADD/ADHD
	The latest ADD / ADHD news from News Medical

	Genetic links to ADHD, autism and depression changed with age The study examines genetic liability for neurodevelopmental disorders, revealing its impact on social functioning and educational attainment across life stages.

	Maternal depression linked to neurodevelopmental disorders in children Children of mothers with depression had higher rates of certain neurodevelopmental disorders regardless of whether they were exposed to antidepressants in the womb, reports a new study led by Saraid McIlvride of the University of Glasgow, UK, published September 29th in the open access journal PLOS Medicine.

			UCL study reveals broad mortality risks faced by ADHD individuals For the study, published in JAMA Network Open, the researchers conducted a systematic review and meta-analysis of 19 studies that included data from close to 16 million study participants on three continents.

			Placental health in late pregnancy linked to childhood ADHD Attention deficit/hyperactivity disorder (ADHD) in children may be associated with problems with the health of the placenta during late pregnancy, according to a new study by University of Iowa Health Care researchers.

			Higher BMI linked to brain differences in preschool children Children as young as 4 with a higher body mass index (BMI) showed differences in several brain regions involved in reward, taste and hunger, according to a new study from Florida International University.

	Study finds no causal link between prenatal paracetamol and neurodevelopmental disorders Various studies over the years have linked prenatal use of the pain reliever paracetamol (acetaminophen) with neurodevelopmental disorders such as autism and attention-deficit/hyperactivity disorder (ADHD) in children, but many of the studies were small, poorly designed, or found only weak associations

	Adults with ADHD face higher risk of developing dementia later in life A new study led by University of Pittsburgh School of Medicine researchers finds that adults with attention-deficit/hyperactivity disorder (ADHD) face a significantly higher risk of developing dementia or mild cognitive impairment later in life.

	ADHD diagnoses rise as awareness improves across Europe, experts say ADHD seems to be in the news everywhere, but is this due to a rise in cases or to changing awareness and diagnosis?

	Short-form video platforms trap users with ADHD in endless loops A study by TU Graz shows that algorithms used by short-form video platforms are particularly effective at keeping people with ADHD engaged.

	OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

	Tracking health misinformation helps pediatricians provide targeted patient education Pediatric clinicians can learn useful information by tracking the health misinformation that their patients encounter, according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition Oct. 2-6, 2026, at the San Diego Convention Center.

	Neurodivergent youth face higher risk of early-onset type 2 diabetes People with neurodiversity, particularly autism and ADHD (attention-deficit/hyperactivity disorder), may be more likely to be diagnosed with type 2 diabetes (T2D) at younger ages, with particularly high prevalence of neurodiversity observed among individuals diagnosed with T2D before the age of 20, finds an analysis of patient data being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy...

	Asian study shows ADHD disability burden peaks in early adolescence Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder and imposes a lifelong burden extending beyond core symptoms to academic achievement, quality of life, and long-term disability.

	OnDosis and Adare Pharma Solutions Announce Strategic Collaboration to Advance OnDosis's Lead U.S. ADHD Program OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney

Copyright © 2000-2026